Sonova Holding AG Overview
Pro stress-test →Sonova Holding AG is a globally active hearing-care group that develops and distributes hearing instruments and related solutions for people with hearing loss. In its 2025/26 financial year (ended May 2026), the company reported group sales of CHF 3.6 billion, up 5.9% in local currencies, driven by 7.5% growth in its combined Wholesale and Retail businesses with sustained market share gains.
Strategic Profile
Pro stress-test →Sonova operates a vertically integrated business model spanning research and development, manufacturing, and worldwide distribution, serving both retail and professional channels with audiologists, hearing-care chains, and clinics. In March 2026, the company announced plans to divest its Consumer Hearing business (Sennheiser brand), concentrating investments on core hearing instruments (Phonak and Unitron brands) and Advanced Bionics cochlear implants. The updated strategy prioritizes driving adoption through innovation with lifestyle-aligned and healthy-aging solutions, succeeding locally with a multi-brand approach, and improving service and operations.
Competitive Landscape
Pro stress-test →Sonova competes with GN Store Nord, Demant, and WS Audiology, holding approximately 20% global market share and leading in premium segments. The company differentiates via Phonak brand's clinical validation and partnerships, such as with Apple for Made for iPhone compatibility. AI integration and direct-to-consumer sales trends favor Sonova's technology-forward positioning.
Industry Context
Sonova Holding AG operates in Hearing aids and cochlear implants.
Key facts
Founded: 1947 · Headquarters: Stäfa, Switzerland · Revenue: 3.6B CHF (FY2025/26) · Market cap: ~19-20B CHF